AstraZenecas (AZN) Imfinzi Gets FDA Nod in Expanded Use
The FDA approves AstraZenecas (AZN) Imfinzi in combination with chemotherapy for treating mismatch repair deficient advanced/recurrent endometrial cancer based on…
£67,298
-50,13%
Echtzeit-Aktienkurs Astrazeneca PLC (Spons. ADRs)
Bid:
Ask:
Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie
AstraZeneca: The Price Upside Is Exhausted For Now (Rating Downgrade)
…
AstraZeneca CFO: Weve come a long way in our oncology portfolio
…
Insmed retains rights to brensocatib after talks with AstraZeneca end By Investing.com
Insmed retains rights to brensocatib after talks with AstraZeneca end…
FDA Expands AstraZenecas (AZN) Farxiga Label in Pediatric T2D
Following the label expansion, AstraZenecas (AZN) Farxiga is now approved to improve glycemic control in patients aged 10 years and…